VVUS Chart
- 52-Week Range: $0.80 - $4.75
- Market Capitalization: $19.65M
- Short Percentage: 0%
- Target Price: $1.75
- Shares Outstanding: 17.87M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
No upcoming catalysts found
News and Press Releases
- Henry Schein Appoints Dirk Benson Chief Commercial Officer, North America Distribution GroupBusiness Wire | May 17th
- 4D pharma conference poster underlines safety and potential efficacy of asthma drug candidateProactive Investors | May 17th
- FDA and Abbott Nutrition reach deal to restart production of baby formula amid nationwide shortageBusiness Insider | May 16th
- Albireo Pharma, Inc. (ALBO) CEO Ron Cooper on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | May 16th
- Celcuity Inc. (CELC) CEO Brian Sullivan on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | May 16th
- Miromatrix Medical Inc. (MIRO) CEO Jeff Ross on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | May 16th
We searched over 50 sources and couldn't find any news or press releases related to VIVUS.
Here are some articles we think you might like.
Company Info
Website: http://www.vivus.com
Address: 900 East Hamilton Avenue, Campbell, CA, United States, 95008
Sector: Healthcare
Industry: Biotechnology
Full time employees: 59
Address: 900 East Hamilton Avenue, Campbell, CA, United States, 95008
Sector: Healthcare
Industry: Biotechnology
Full time employees: 59
$VVUS Bearish..
$VVUS here to raid
$VVUS hint hint this is when you buy a few
$VVUS go green today and we gap up tomrrow
$VVUS no pain no gain
$VVUS hold
$VVUS like if you’re buying Monday!! Let’s Go!!